[1]
“Public Perception of Fraudulent Financial Statements in Pharmaceutical Sub Sector”, Journal of Pharmaceutical Negative Results, pp. 1577–1584, Nov. 2022, doi: 10.47750/pnr.2022.13.S09.194.